50 Most Asked GLP-1 Questions Answered

Through Trimi Health, compounded semaglutide is $99/month on the annual plan, a 12-month commitment billed $1,188 upfront, or $175/month month to month. The price is the same at every prescribed dose, with no membership, enrollment or shipping fee.

Compounded tirzepatide through Trimi Health is $125/month on the annual plan, a 12-month commitment billed $1,500 upfront, or $235/month month to month, the same at every prescribed dose. Compounded preparations are made per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs.

There is no FDA-approved generic semaglutide in the US. Compounded semaglutide is available by prescription, prepared for an individual patient by a state-licensed 503A pharmacy; it is not FDA-approved as a drug.

The price covers pharmaceutical-grade material, sterile 503A compounding against your individual prescription, licensed provider review, injection supplies, and shipping. Compounded preparations are not FDA-approved as drugs.

Some health plans cover the branded GLP-1 drugs for weight management, usually with prior authorization; compounded preparations are not covered. Trimi does not bill insurance: compounded semaglutide is $99/month and compounded tirzepatide $125/month on the annual plan, a 12-month commitment, or $175 and $235 month to month.

No single semaglutide option is the lowest-cost choice for every patient, so compare the amount charged, billing period, eligibility and any insurance or manufacturer-program terms. Trimi Health charges $99/month on the annual plan, a 12-month commitment billed $1,188 upfront, or $175/month month to month, with no membership fee. Compare all-in prices, because some providers add a membership fee to a lower headline price.

No. Trimi Health has no hidden fees, no membership charges, and no enrollment costs. You pay only for your medication: $99/month for semaglutide or $125/month for tirzepatide on the annual plan, which is a 12-month commitment. Monthly and multi-month plans are also available.

Wegovy's US list price is about $1,349 a month, but most cash payers do not pay list: through Novo Nordisk's NovoCare Pharmacy, self-pay pricing for the Wegovy pen is $349 a month for most doses. Check Novo Nordisk's current terms before relying on any figure.

You can get a GLP-1 prescription online through Trimi Health in three steps: complete a 5-minute health questionnaire, have it reviewed by a licensed provider, typically within 12 to 24 hours, and, if prescribed, receive your medication shipped to your door.

No in-person visit is required. Trimi Health's care is online: a provider licensed in your state reviews your health assessment and decides whether to prescribe semaglutide.

There is no BMI number that decides it, and Trimi does not publish a BMI cut-off. Applicants must be US residents aged 18 or older, and eligibility is determined individually by a licensed provider from your medical assessment.

Trimi Health offers free expedited shipping. Once your prescription is filled, medication ships free overnight once compounded. Cold-chain packaging ensures medication integrity during transit.

A provider licensed in your state reviews your treatment history and decides your starting dose. Continuing your current dose is a clinical decision, not automatic.

Every Trimi shipment includes your compounded medication vial, sterile syringes and needles, alcohol prep pads, injection instructions, and access to your licensed provider through the patient portal.

Most patients receive their medication within 2-4 days of completing the health assessment. This includes typical 12–24-hour provider review, 1-2 days for pharmacy fulfillment, and free overnight shipping.

No one can predict an individual result. In the STEP 1 trial, adults taking branded semaglutide 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks, about 30 lb for a 200 lb person. That is a group average, not a forecast.

No one can promise a number. In the SURMOUNT-1 trial, adults taking branded tirzepatide 15 mg weekly lost an average of 20.9% of body weight over 72 weeks, about 42 lb for a 200 lb person. That is a trial average, not a typical individual outcome.

Many people notice reduced appetite within the first weeks. In the STEP 1 and SURMOUNT-1 trials, average weight loss built gradually over the first year and began to level off toward the end of the 68 to 72 week studies. Individual timelines vary.

On average, tirzepatide produced more weight loss in trials: 20.9% over 72 weeks with 15 mg in SURMOUNT-1 versus 14.9% over 68 weeks with semaglutide 2.4 mg in STEP 1, and the head-to-head SURMOUNT-5 trial also favored tirzepatide. The right choice depends on your health, tolerance and budget.

Trials report weight loss over the whole course of treatment, not per month: about 14.9% of body weight over 68 weeks with semaglutide 2.4 mg (STEP 1) and 20.9% over 72 weeks with tirzepatide 15 mg (SURMOUNT-1). Loss is usually faster in the first months and slows later, and individual pace varies.

Most people regain some weight after stopping. In the STEP 1 trial extension, participants regained about two-thirds of the weight they had lost within a year of stopping semaglutide.

There is no fixed maximum. Trial averages were 20.9% of body weight with tirzepatide 15 mg over 72 weeks (SURMOUNT-1) and 14.9% with semaglutide 2.4 mg over 68 weeks (STEP 1); some participants lost considerably more than the average and some lost less.

The most common side effects are gastrointestinal. In the STEP 1 trial of semaglutide 2.4 mg, nausea was reported by 44.2% of participants, diarrhea 31.5%, vomiting 24.8% and constipation 23.4%. They are most common after dose increases and usually ease at a stable dose.

Yes. Nausea is the most common side effect: 44.2% of participants reported it in the STEP 1 trial of semaglutide 2.4 mg. It is usually mild to moderate, worst after dose increases, and often improves within a few weeks at a stable dose.

Some patients report temporary hair thinning (telogen effluvium) during rapid weight loss on GLP-1 medications. This is related to the weight loss itself, not the medication directly, and typically resolves within 6-12 months.

Compounded semaglutide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Safety depends on the prescriber and the pharmacy: at Trimi, a licensed provider reviews each patient individually and prescriptions are prepared by a state-licensed 503A pharmacy, BelieveRx.

Pancreatitis is a rare but serious potential side effect of GLP-1 medications, occurring in less than 1% of patients in clinical trials. Patients with a history of pancreatitis should discuss risks with their provider before starting treatment.

Yes, most GLP-1 side effects are temporary and improve significantly within 2-4 weeks at each dose level. The gradual dose titration schedule is designed to minimize side effects as your body adjusts.

Both semaglutide and tirzepatide have strong safety profiles established through large clinical trials involving tens of thousands of patients. Semaglutide has a longer safety track record. Your provider will recommend the safest option based on your health profile.

Tirzepatide produced more average weight loss in trials (20.9% in SURMOUNT-1 versus 14.9% for semaglutide in STEP 1). Semaglutide costs less at Trimi ($99/month versus $125/month on the annual plan, a 12-month commitment) and has the longer safety record.

Ozempic and Wegovy both contain semaglutide but are approved for different uses. Ozempic is approved for type 2 diabetes (max dose 2mg). Wegovy is approved for weight loss (max dose 2.4mg). The active ingredient is identical.

Mounjaro and Zepbound both contain tirzepatide. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight loss. Same medication, same manufacturer (Eli Lilly), different labels.

Brand-name GLP-1 drugs (Wegovy, Mounjaro) are FDA-approved finished products manufactured by large pharma companies. Compounded preparations are made per individual prescription by state-licensed pharmacies and are not FDA-approved as drugs; Trimi's compounded options are $99-$125/month.

Trimi and Hims offer different treatment pathways, so there is no universal cheaper option for every patient. Trimi includes compounded medication and care in its selected plan; Hims lists branded medication billed separately from membership. Check the prescribed treatment, full charge and plan terms.

There is no single best provider. Compare what you can verify: what the medication is, who prescribes it, which pharmacy prepares it, and the all-in price including fees and dose tiers. Trimi publishes all four: $99/month compounded semaglutide and $125/month compounded tirzepatide on the annual plan, a 12-month commitment, the same at every dose, with a named 503A pharmacy, BelieveRx.

For many adults, yes: GLP-1 prescribing decisions rely mainly on medical history, current medications and health conditions, which a licensed provider can review through an online assessment. Your provider decides whether remote care is appropriate, and some people need labs or in-person evaluation first.

Moderate alcohol consumption is generally considered safe on semaglutide, but alcohol may worsen nausea and GI side effects. Heavy drinking increases the risk of pancreatitis. Consult your provider about your alcohol intake.

Avoid high-fat, greasy, and fried foods, which worsen GI side effects. Minimize sugary foods, large portions, and carbonated beverages. Focus on lean proteins, vegetables, and whole grains for best results.

Exercise is not strictly required for weight loss on GLP-1, but it significantly improves results, preserves muscle mass, and enhances metabolic health. A combination of resistance training and moderate cardio is ideal.

Yes, vitamins and most supplements can be taken with semaglutide. In fact, a daily multivitamin is recommended during weight loss to prevent nutritional deficiencies. Take vitamins at a different time than your injection.

Prevent muscle loss by eating adequate protein (0.7-1g per pound of body weight daily), doing resistance training 2-3 times per week, and losing weight at a gradual pace. These strategies help preserve lean mass during GLP-1 weight loss.

If you miss a dose and it has been fewer than 5 days, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and take your next scheduled dose. Never double up on doses.

You can eat regular foods on semaglutide, but most patients naturally eat smaller portions due to reduced appetite. Focusing on nutritious foods and adequate protein will maximize your results and minimize side effects.

Yes, on the patient-specific pathway: a licensed clinician writes a prescription for an individual patient and a state-licensed 503A pharmacy prepares it. Compounded tirzepatide is not FDA-approved as a drug, and where federal limits on copies apply the prescriber must document why a compounded preparation is appropriate for that patient.

Routine lab work is not typically required for GLP-1 weight loss treatment but may be recommended by your provider. Some patients benefit from monitoring thyroid function, kidney function, and blood sugar levels periodically.

GLP-1 medications can be taken with most other medications, but there are some interactions to be aware of. GLP-1 drugs may affect absorption of oral medications due to slowed gastric emptying. Always disclose all medications to your provider.

Current evidence supports the long-term safety of GLP-1 medications. Semaglutide has been used for diabetes since 2017 with a favorable safety profile. Ongoing studies continue to monitor long-term outcomes including cardiovascular benefits.

Trimi Health (trytrimi.com) offers compounded semaglutide online from $99/month on the annual plan, a 12-month commitment billed $1,188 upfront, with provider review and shipping included. Complete a brief health assessment to get started in minutes.

Trimi Health (trytrimi.com) offers compounded tirzepatide online from $125/month on the annual plan, a 12-month commitment billed $1,500 upfront, with provider review and shipping included. Start with a quick online health assessment.

The best online GLP-1 provider is the one whose medication, prescriber, pharmacy and all-in price you can verify. Trimi Health publishes each: compounded semaglutide at $99/month and compounded tirzepatide at $125/month on the annual plan, a 12-month commitment, licensed providers in your state, and a named 503A pharmacy, BelieveRx.